vs
Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.
NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $162.5M, roughly 1.1× Bitcoin Depot Inc.). Bitcoin Depot Inc. runs the higher net margin — 3.4% vs -57.9%, a 61.3% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs 11.1%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs -4.9%).
Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
BTM vs NEO — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $162.5M | $186.7M |
| Net Profit | $5.5M | $-108.0M |
| Gross Margin | — | 43.3% |
| Operating Margin | 7.3% | 46.9% |
| Net Margin | 3.4% | -57.9% |
| Revenue YoY | 20.1% | 11.1% |
| Net Profit YoY | 690.4% | 42.0% |
| EPS (diluted) | $0.08 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $186.7M | ||
| Q4 25 | — | $190.2M | ||
| Q3 25 | $162.5M | $187.8M | ||
| Q2 25 | $172.1M | $181.3M | ||
| Q1 25 | $164.2M | $168.0M | ||
| Q4 24 | — | $172.0M | ||
| Q3 24 | $135.3M | $167.8M | ||
| Q2 24 | $163.1M | $164.5M |
| Q1 26 | — | $-108.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | $5.5M | $-27.1M | ||
| Q2 25 | $6.1M | $-45.1M | ||
| Q1 25 | $4.2M | $-25.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-939.0K | $-17.7M | ||
| Q2 24 | $-2.6M | $-18.6M |
| Q1 26 | — | 43.3% | ||
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 42.6% | ||
| Q1 25 | — | 43.6% | ||
| Q4 24 | — | 44.9% | ||
| Q3 24 | — | 44.6% | ||
| Q2 24 | — | 44.1% |
| Q1 26 | — | 46.9% | ||
| Q4 25 | — | -7.1% | ||
| Q3 25 | 7.3% | -14.4% | ||
| Q2 25 | 9.2% | -26.3% | ||
| Q1 25 | 10.8% | -16.6% | ||
| Q4 24 | — | -10.7% | ||
| Q3 24 | 4.1% | -12.6% | ||
| Q2 24 | 4.7% | -13.3% |
| Q1 26 | — | -57.9% | ||
| Q4 25 | — | — | ||
| Q3 25 | 3.4% | -14.4% | ||
| Q2 25 | 3.5% | -24.9% | ||
| Q1 25 | 2.6% | -15.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.7% | -10.5% | ||
| Q2 24 | -1.6% | -11.3% |
| Q1 26 | — | $-0.13 | ||
| Q4 25 | — | — | ||
| Q3 25 | $0.08 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.20 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.13 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $146.1M |
| Total DebtLower is stronger | $67.5M | — |
| Stockholders' EquityBook value | $21.0M | $828.8M |
| Total Assets | $125.3M | $1.3B |
| Debt / EquityLower = less leverage | 3.21× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $146.1M | ||
| Q4 25 | — | $159.6M | ||
| Q3 25 | $59.3M | $164.1M | ||
| Q2 25 | $48.0M | $154.7M | ||
| Q1 25 | $35.0M | $346.2M | ||
| Q4 24 | — | $367.0M | ||
| Q3 24 | $32.2M | $362.0M | ||
| Q2 24 | $43.9M | $355.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $341.9M | ||
| Q3 25 | $67.5M | — | ||
| Q2 25 | $66.5M | — | ||
| Q1 25 | $56.2M | — | ||
| Q4 24 | — | $541.1M | ||
| Q3 24 | $44.5M | — | ||
| Q2 24 | $41.2M | — |
| Q1 26 | — | $828.8M | ||
| Q4 25 | — | $836.6M | ||
| Q3 25 | $21.0M | $838.3M | ||
| Q2 25 | $4.7M | $854.0M | ||
| Q1 25 | $-4.6M | $888.3M | ||
| Q4 24 | — | $902.3M | ||
| Q3 24 | $-7.9M | $908.2M | ||
| Q2 24 | $4.4M | $915.9M |
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $125.3M | $1.4B | ||
| Q2 25 | $109.1M | $1.4B | ||
| Q1 25 | $89.7M | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $87.4M | $1.6B | ||
| Q2 24 | $97.5M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.41× | ||
| Q3 25 | 3.21× | — | ||
| Q2 25 | 14.18× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | 9.27× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $-8.1M |
| Free Cash FlowOCF − Capex | $2.5M | — |
| FCF MarginFCF / Revenue | 1.6% | — |
| Capex IntensityCapex / Revenue | 2.5% | — |
| Cash ConversionOCF / Net Profit | 1.20× | — |
| TTM Free Cash FlowTrailing 4 quarters | $27.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-8.1M | ||
| Q4 25 | — | $1.3M | ||
| Q3 25 | $6.6M | $8.9M | ||
| Q2 25 | $10.2M | $20.3M | ||
| Q1 25 | $16.3M | $-25.3M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | $5.8M | $9.2M | ||
| Q2 24 | $10.1M | $13.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-6.5M | ||
| Q3 25 | $2.5M | $570.0K | ||
| Q2 25 | $9.8M | $14.0M | ||
| Q1 25 | $15.9M | $-29.8M | ||
| Q4 24 | — | $-1.8M | ||
| Q3 24 | $-1.0M | $-1.6M | ||
| Q2 24 | $7.6M | $814.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | -3.4% | ||
| Q3 25 | 1.6% | 0.3% | ||
| Q2 25 | 5.7% | 7.7% | ||
| Q1 25 | 9.7% | -17.8% | ||
| Q4 24 | — | -1.0% | ||
| Q3 24 | -0.8% | -0.9% | ||
| Q2 24 | 4.7% | 0.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.1% | ||
| Q3 25 | 2.5% | 4.4% | ||
| Q2 25 | 0.2% | 3.5% | ||
| Q1 25 | 0.2% | 2.7% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | 5.0% | 6.4% | ||
| Q2 24 | 1.5% | 8.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.67× | — | ||
| Q1 25 | 3.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
